Literature DB >> 25791218

The osteocyte plays multiple roles in bone remodeling and mineral homeostasis.

Huayue Chen1, Takao Senda, Kin-ya Kubo.   

Abstract

Osteocytes are the most abundant cells in bone and are the major orchestrators of bone remodeling and mineral homeostasis. They possess a specialized cellular morphology and a unique molecular feature. Osteocytes are a stellate shape with numerous long, slender dendritic processes. The osteocyte cell body resides in the bone matrix of the lacuna and the dendritic processes extend within the canaliculi to adjacent osteocytes and other cells on the bone surface. Osteocytes form extensive intercellular network to sense and respond to environmental mechanical stimulus by the lacunar-canalicular system and gap junction. Osteocytes are long-lived bone cells. They can undergo apoptosis, which may have specific regulatory effects on osteoclastic bone resorption. Osteocytes can secrete several molecules, including sclerostin, receptor activator of nuclear factor κB ligand and fibroblast growth factor 23 to regulate osteoblastic bone formation, osteoclastic bone resorption and mineral homeostasis. A deeper understanding of the complex mechanisms that mediate the control of osteoblast and osteoclast function by osteocytes may identify new osteocyte-derived molecules as potential pharmacological targets for treating osteoporosis and other skeletal diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25791218     DOI: 10.1007/s00795-015-0099-y

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  72 in total

Review 1.  Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases.

Authors:  Hua Zhu Ke; William G Richards; Xiaodong Li; Michael S Ominsky
Journal:  Endocr Rev       Date:  2012-06-20       Impact factor: 19.871

Review 2.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

3.  Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.

Authors:  J Ignacio Aguirre; Lilian I Plotkin; Scott A Stewart; Robert S Weinstein; A Michael Parfitt; Stavros C Manolagas; Teresita Bellido
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

4.  Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.

Authors:  Faryal S Mirza; I Desmond Padhi; Lawrence G Raisz; Joseph A Lorenzo
Journal:  J Clin Endocrinol Metab       Date:  2010-02-15       Impact factor: 5.958

5.  Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip.

Authors:  R S Weinstein; R W Nicholas; S C Manolagas
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

6.  Hormonal, pH, and calcium regulation of connexin 43-mediated dye transfer in osteocytes in chick calvaria.

Authors:  Yoshihito Ishihara; Hiroshi Kamioka; Tadashi Honjo; Hirotaka Ueda; Teruko Takano-Yamamoto; Takashi Yamashiro
Journal:  J Bone Miner Res       Date:  2008-03       Impact factor: 6.741

7.  Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.

Authors:  Xiaodong Li; Michael S Ominsky; Kelly S Warmington; Sean Morony; Jianhua Gong; Jin Cao; Yongming Gao; Victoria Shalhoub; Barbara Tipton; Raj Haldankar; Qing Chen; Aaron Winters; Tom Boone; Zhaopo Geng; Qing-Tian Niu; Hua Zhu Ke; Paul J Kostenuik; W Scott Simonet; David L Lacey; Chris Paszty
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

8.  Targeted deletion of Sost distal enhancer increases bone formation and bone mass.

Authors:  Nicole M Collette; Damian C Genetos; Aris N Economides; LiQin Xie; Mohammad Shahnazari; Wei Yao; Nancy E Lane; Richard M Harland; Gabriela G Loots
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-10       Impact factor: 11.205

9.  A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis.

Authors:  Alison Eddleston; Massimo Marenzana; Adrian R Moore; Paul Stephens; Mariusz Muzylak; Diane Marshall; Martyn K Robinson
Journal:  J Bone Miner Res       Date:  2009-10       Impact factor: 6.741

10.  Ultrastructural changes in bones of the senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis.

Authors:  H Chen; S Shoumura; S Emura
Journal:  Histol Histopathol       Date:  2004-07       Impact factor: 2.303

View more
  31 in total

1.  Phosphate toxicity: a stealth biochemical stress factor?

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Med Mol Morphol       Date:  2015-11-18       Impact factor: 2.309

Review 2.  Changes in the osteocyte lacunocanalicular network with aging.

Authors:  LeAnn M Tiede-Lewis; Sarah L Dallas
Journal:  Bone       Date:  2019-02-08       Impact factor: 4.398

3.  Tumor dormancy in bone.

Authors:  Vera Mayhew; Tolu Omokehinde; Rachelle W Johnson
Journal:  Cancer Rep (Hoboken)       Date:  2019-01-29

4.  A Novel Osteogenic Cell Line That Differentiates Into GFP-Tagged Osteocytes and Forms Mineral With a Bone-Like Lacunocanalicular Structure.

Authors:  Kun Wang; Lisa Le; Brad M Chun; LeAnn M Tiede-Lewis; Lora A Shiflett; Matthew Prideaux; Richard S Campos; Patricia A Veno; Yixia Xie; Vladimir Dusevich; Lynda F Bonewald; Sarah L Dallas
Journal:  J Bone Miner Res       Date:  2019-06-07       Impact factor: 6.741

Review 5.  Mechanisms of RANKL delivery to the osteoclast precursor cell surface.

Authors:  Masashi Honma; Yuki Ikebuchi; Hiroshi Suzuki
Journal:  J Bone Miner Metab       Date:  2020-10-12       Impact factor: 2.626

Review 6.  Lung-resident mesenchymal stromal cells are tissue-specific regulators of lung homeostasis.

Authors:  Stefanie Noel Sveiven; Tara M Nordgren
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-13       Impact factor: 5.464

Review 7.  Pro-inflammatory Cytokines and Osteocytes.

Authors:  Miao Zhou; Shuyi Li; Janak L Pathak
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

Review 8.  Morphological and molecular characterization of the senile osteoporosis in senescence-accelerated mouse prone 6 (SAMP6).

Authors:  Kagaku Azuma; Qian Zhou; Kin-Ya Kubo
Journal:  Med Mol Morphol       Date:  2018-04-04       Impact factor: 2.309

Review 9.  Using confocal imaging approaches to understand the structure and function of osteocytes and the lacunocanalicular network.

Authors:  Sarah L Dallas; David S Moore
Journal:  Bone       Date:  2020-06-06       Impact factor: 4.398

Review 10.  The pathophysiology of immunoporosis: innovative therapeutic targets.

Authors:  Mouna Ferbebouh; Francis Vallières; Mohamed Benderdour; Julio Fernandes
Journal:  Inflamm Res       Date:  2021-07-16       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.